-+ 0.00%
-+ 0.00%
-+ 0.00%

NovoCure Earnings Report: Q4 Overview

Benzinga·02/26/2026 12:04:22
Listen to the news

NovoCure (NASDAQ:NVCR) reported its Q4 earnings results on Thursday, February 26, 2026 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure beat estimated earnings by 46.34%, reporting an EPS of $-0.22 versus an estimate of $-0.41.

Revenue was up $13.08 million from the same period last year.

Past Earnings Performance

The company beat on EPS by $0.09 in the last quarter, resulting in a 0.08% drop share price change the following day.

Here's a look at NovoCure's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.42 -0.39 -0.46 -0.34
EPS Actual -0.33 -0.36 -0.31 -0.61
Revenue Estimate 158.34M 153.51M 147.00M 161.30M
Revenue Actual 167.20M 158.81M 154.99M 161.27M

To track all earnings releases for NovoCure visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.